Abstract View: 1933
PDF Download: 778
Report
Points to Consider Regarding Tobacco Hindrance
Negar Rezaei
1, Farshad Farzadfar
1*1 Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
*Corresponding Author: *Corresponding Author: Farshad Farzadfar, MD, MPH, MHS, DSc; Chair of Non-Communicable Diseases Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Second Floor, No.10, Jalal Al-e-Ahmad Highway, Tehran, Iran. Tel: +98-21-88631293, Email: f-farzadfar@tums.ac.ir; , Email:
farzadfar3@yahoo.com
Cite this article as: Rezaei N, Farzadfar F. Points to consider regarding tobacco hindrance. Arch Iran Med. 2020;23(5):353–355. doi: 10.34172/aim.2020.25.
Abstract View: 1934
years | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
2024 | 43 | 29 | 20 | 19 | 17 | 15 | 15 | 25 | 33 | 40 | 38 | 55 |
2023 | 32 | 21 | 25 | 24 | 22 | 24 | 17 | 16 | 25 | 23 | 56 | 34 |
2022 | 39 | 33 | 35 | 26 | 28 | 30 | 27 | 19 | 38 | 29 | 31 | 34 |
2021 | 30 | 26 | 25 | 26 | 40 | 26 | 28 | 35 | 40 | 34 | 34 | 47 |
2020 | | | | | 164 | 93 | 47 | 61 | 44 | 35 | 40 | 22 |
PDF Download: 778
years | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
2024 | 10 | 10 | 7 | 20 | 11 | 12 | 10 | 10 | 14 | 19 | 14 | 9 |
2023 | 27 | 17 | 18 | 15 | 15 | 17 | 18 | 15 | 18 | 11 | 20 | 11 |
2022 | 15 | 12 | 11 | 12 | 24 | 12 | 11 | 15 | 18 | 10 | 19 | 19 |
2021 | 11 | 8 | 7 | 11 | 7 | 7 | 4 | 13 | 11 | 11 | 15 | 8 |
2020 | | | | | 68 | 23 | 8 | 11 | 10 | 8 | 6 | 5 |